SCOPUS 정보 검색 플랫폼

Volumn 70, Issue 1, 2001, Pages 55-63

An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer

(7) Bonnefoi, H a Biganzoli, L b Cufer, T c Mauriac, L d Hamilton, A b Schaefer, P a Piccart, M e

a GENEVA UNIVERSITY HOSPITALS (Switzerland)

b EORTC DATA CENTER (Belgium)

c INSTITUTE OF ONCOLOGY (Slovenia)

d INSTITUT BERGONIÉ (France)

e JULES BORDET INSTITUTE (Belgium)

Author keywords

Breast cancer; Epirubicin; Infusional 5 fluorouracil; Neoadjuvant chemotherapy

Indexed keywords

CAPECITABINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADULT; ALOPECIA; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DYSESTHESIA; FEBRILE NEUTROPENIA; FEMALE; HUMAN; MAXIMUM TOLERATED DOSE; MUCOSA INFLAMMATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SURGICAL APPROACH; THROMBOCYTOPENIA;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DRUG ADMINISTRATION SCHEDULE; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; INJECTIONS, INTRAVENOUS; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0035201299 PISSN: 01676806 EISSN: None Source Type: Journal
DOI: 10.1023/A:1012530607649 Document Type: Article

Times cited : (7)

References (23)

1
- 0028229054
- Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer: An active new regimen
- (1994) J Clin Oncol , vol.12 , pp. 1259-1265
- Jones, A.L.¹ Smith, I.E.² O'Brien, M.E.R.³ Talbot, D.⁴ Walsh, G.⁵ Ramage, F.⁶ Robertshaw, H.⁷ Ashley, S.⁸

2
- 0030049344
- Phase II study of infusional 5-fluorouracil with epirubicin and carboplatin (instead of cisplatin) in patients with metastatic/locally advanced breast cancer (infusional ECarboF): A very active and well tolerated outpatient regimen
- (1996) Br J Cancer , vol.73 , pp. 391-396
- Bonnefoi, H.¹ Smith, I.E.² O'Brien, M.E.R.³ Seymour, M.T.⁴ Powles, T.J.⁵ Allum, W.H.⁶ Ebbs, S.⁷ Baum, M.⁸

3
- 0028890177
- High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer
- (1995) J Clin Oncol , vol.13 , pp. 424-429
- Smith, I.E.¹ Walsh, G.² Jones, A.³ Prendiville, J.⁴ Johnston, B.⁵ Gusterson, B.⁶ Ramage, F.⁷ Robertshaw, H.⁸ Sacks, N.⁹ Ebbs, S.¹⁰ McKinna, J.A.¹¹ Baum, M.¹²

4
- 0031949961
- Randomized phase II trial of infusional fluorouracil, epirubicin, and cyclophosphamide versus infusional fluorouracil, epirubicin, and cisplatin in patients with advanced breast cancer
- (1998) J Clin Oncol , vol.16 , pp. 1350-1357
- Eisen, T.¹ Smith, I.E.² Johnston, S.³ Ellis, P.A.⁴ Prendiville, J.⁵ Seymour, M.T.⁶ Walsh, G.⁷ Ashley, S.⁸

5
- 0025910589
- Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm
- (1991) Ann Oncol , vol.2 , pp. 347-354
- Mauriac, L.¹ Durand, M.² Avril, A.³ Dilbuydy, J.M.⁴

6
- 0028048459
- Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer
- (1994) Ann Oncol , vol.5 , pp. 591-595
- Semiglazov, V.F.¹ Topuzov, E.E.² Bavli, J.L.³ Moiseyenko, V.M.⁴ Ivanova, O.A.⁵ Seleznev, I.K.⁶ Orlov, A.A.⁷ Barash, N.Y.⁸ Golubeva, O.M.⁹ Chepic, O.F.¹⁰

7
- 0000250365
- Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery. An update
- (1995) Proc Am Soc Clin Oncol , vol.14 , pp. 125
- Scholl, S.M.¹ Asselain, B.² Beuzeboc, P.³ Pierga, J.Y.⁴ Dorval, T.⁵ Garcia-Giralt, E.⁶ Jouve, M.⁷ Palangié, T.⁸ Fourquet, A.⁹ Durand, J.C.¹⁰ Pouillart, P.¹¹

8
- 0031926839
- Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
- (1998) J Clin Oncol , vol.16 , pp. 2672-2685
- Fisher, B.¹ Bryant, J.² Wolmark, N.³ Mamounas, E.⁴ Brown, A.⁵ Fisher, E.R.⁶ Wickerham, D.L.⁷ Begovic, M.⁸ DeCillis, A.⁹ Robidoux, A.¹⁰ Margolese, R.G.¹¹ Cruz, A.B.¹² Hoehn, J.L.¹³ Lees, A.W.¹⁴ Dimitrov, N.V.¹⁵ Bear, H.D.¹⁶

9
- 0028357653
- Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6
- (1994) Eur J Cancer , vol.30 A , pp. 645-652
- Scholl, S.M.¹ Fourquet, A.² Asselain, B.³ Pierga, J.Y.⁴ Vilcoq, J.R.⁵ Durand, J.C.⁶ Dorval, T.⁷ Palangié, T.⁸ Jouve, M.⁹ Beuzeboc, P.¹⁰ Garcia-Giralt, E.¹¹ Salmon, R.J.¹² De la Rochefordière, A.¹³ Campana, F.¹⁴ Pouillart, P.¹⁵

10
- 0028941377
- Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer
- (1995) J Clin Oncol , vol.13 , pp. 547
- Powles, T.J.¹ Hickish, T.F.² Makris, A.³ Ashley, S.E.⁴ O'Brien, M.E.⁵ Tidy, V.A.⁶ Casey, S.⁷ Nash, A.G.⁸ Sacks, N.⁹ Cosgrove, D.¹⁰ MacVicar, D.¹¹ Fernando, I.¹² Ford, H.T.¹³

11
- 0028274962
- Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma
- (1994) N Engl J Med , vol.330 , pp. 1253-1259
- Wood, W.C.¹ Budman, D.R.² Korzun, A.H.³ Robert Cooper, M.⁴ Younger, J.⁵ Hart, R.D.⁶ Moore, A.⁷ Ellerton, J.A.⁸ Norton, L.⁹ Ferree, C.R.¹⁰ Colangelo Ballow, A.¹¹ Frei III, E.¹² Craig Henderson, I.¹³

12
- 0035253733
- Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5 Year follow-up results of French adjuvant study group 05 randomized trial
- (2001) J Clin Oncol , vol.19 , pp. 602-611

13
- 0003575141
- DCTD, NCI, NIH, DHHS, March
- (1998) Common Toxicity Criteria. Version 2.0

14
- 0003486931
- WHO Offset Publication, Geneva (Switzerland)
- WHO Handbook for Reporting Results of Cancer Treatment No. 48

15
- 0025237877
- Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial
- (1990) Ann Intern Med , vol.112 , pp. 423-428
- Bern, M.M.¹ Lokich, J.J.² Wallach, S.R.³ Bothe, A.⁴ Benotti, P.N.⁵ Arkin, C.F.⁶ Greci, F.A.⁷ Huberman, M.⁸ Moore, C.⁹

16
- 0027506071
- A pilot study of intensive cyclophosphamide, epirubicin and fluorouracil in patients with axillary node positive or locally advanced breast cancer
- (1993) Eur J Cancer , vol.29 A , pp. 37-43
- Levine, M.N.¹ Bramwell, V.² Pritchard, K.³ Perrault, D.⁴ Findlay, B.⁵ Abu-Zahra, H.⁶ Warr, D.⁷ Arnold, A.⁸ Skillings, J.⁹

17
- 0021710953
- Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome
- (1984) Ann Inter Med , vol.101 , pp. 798-800
- Lokich, J.J.¹ Moore, C.²

18
- 8044260248
- Weekly doxorubicin and continuous influsional 5-fluorouracil for advanced breast cancer
- (1996) Br J Cancer , vol.74 , pp. 2008-2012
- Gabra, H.¹ Cameron, D.A.² Lee, L.E.³ Mackay, J.⁴ Leonard, R.C.F.⁵

19
- 0023583165
- Continuous 5-fluorouracil infusion in refractory carcinoma of the breast
- (1987) Breast Cancer Res Treat , vol.10 , pp. 145-149
- Hansen, R.¹ Quebbeman, E.² Beatty, P.³ Ritch, P.⁴ Anderson, T.⁵ Jenkins, D.⁶ Frick, J.⁷ Ausman, R.⁸

20
- 0000014308
- Preoperative continuous infusional ECisF (Epirubicin, Cisplatin and Infusional 5-FU) v. conventional AC chemotherapy for early breast cancer: A phase III multicentre randomised trial by the topic trial group
- (2000) Proc Am Soc Clin Oncol , vol.19
- Smith, I.E.¹ A'Hern, R.P.² Howell, A.³ Hickish, T.⁴ O'Brien, M.⁵ Mansi, J.⁶ Wilson, C.⁷ Robinson, A.⁸ Pratt, W.⁹ Price, C.¹⁰ Perren, T.¹¹ Laing, R.¹²

21
- 0031859855
- Preliminary studies of a novel oral fluoropyrimidine carbamate: Capecitabine
- (1998) J Clin Oncol , vol.16 , pp. 1795-1802
- Budman, D.R.¹ Meropol, N.J.² Reigner, B.³ Creaven, P.J.⁴ Lichtman, S.M.⁵ Berghorn, E.⁶ Behr, J.⁷ Gordon, R.J.⁸ Osterwalder, B.⁹ Griffin, B.¹⁰

22
- 0000092361
- Antitumor efficacy of capecitabine against fluorouracil-sensitive and resistant tumors
- (1997) Proc Am Soc Clin Oncol , vol.16
- Cao, S.¹ Lu, K.² Ishitsuka, H.³

23
- 0001556678
- Xeloda (capecitabine): An orally available tumor selective fluoropyrimidine cabamate
- (1997) Proc Am Soc Clin Oncol , vol.16
- Ishikawa, T.¹ Utoh, M.² Sawada, N.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.